exsgpguy

Merck, Schering-Plough Waste Money on Ineffective Allergy Drug

I worked at Schering-Plough in the 80's, 90's and 00's. I was very involved in the US pharma business and we had concluded in the early 00's that based upon studies we performed with the combo product there was no benefit vs the individual products alone. The new S-P team resurrected this "dead" product as a last gasp to prove they are smarter than previous management. All they did was waste shareholder money and FDA time. Unless they were going down the data manipulation road they tried with the ENHANCE study until they got caught.